Smokers hopeful new drug breaks habit
August 2, 2006Chantix, a new stop-smoking drug that partially activates nicotine receptors in the brain, has arrived on the U.S. market.
USA Today says the new drug is different from other products because it levels out the peaks and dips from the roller coaster of nicotine addiction.
In clinical trials, about 22 percent of patients who took Chantix in clinical trials were still not smoking after a year. Thomas Glynn, director of cancer science at the American Cancer Society, told USA Today that fewer than 5 percent of smokers who try to quit on their own can last a year without a cigarette.
The newspaper said Acomplia, a drug available in Europe for weight loss, also has shown potential for helping smokers quit but it has not been approved for use in the United States.
Copyright 2006 by United Press International
-
Low dopamine levels during withdrawal promote relapse to smoking
Feb 08, 2012 |
not rated yet |
0
-
Nicotine replacement therapies may not be effective in helping people quit smoking, study says
Jan 09, 2012 |
3 / 5 (1) |
3
-
Starting smoking cessation medication earlier may make it easier to quit
Jan 05, 2012 |
5 / 5 (1) |
1
-
Preventive care: It's free, except when it's not
Dec 28, 2011 |
5 / 5 (4) |
8
-
Dutch government backtracks on anti-smoking
Dec 14, 2011 |
not rated yet |
0
-
Engineers build first sub-10-nm carbon nanotube transistor
Feb 01, 2012 |
4.9 / 5 (30) |
30
-
Something old, something new: Evolution and the structural divergence of duplicate genes
Jan 31, 2012 |
4.6 / 5 (7) |
1
-
The hidden nanoworld of ice crystals: Revealing the dynamic behavior of quasi-liquid layers
Jan 30, 2012 |
5 / 5 (3) |
1
-
Stock market network reveals investor clustering
Jan 27, 2012 |
3.9 / 5 (23) |
8
-
Of microchemistry and molecules: Electronic microfluidic device synthesizes biocompatible probes
Jan 26, 2012 |
5 / 5 (1) |
0
More news stories
New understanding of DNA repair could eventually lead to cancer therapy
A research group in the Faculty of Medicine & Dentistry at the University of Alberta is hoping its latest discovery could one day be used to develop new therapies that target certain types of cancers.
55 minutes ago |
5 / 5 (3) |
0
|
Researchers develop new method for creating tissue engineering scaffolds
Researchers at Northwestern University have developed a new method for creating scaffolds for tissue engineering applications, providing an alternative that is more flexible and less time-intensive than current technology.
8 minutes ago |
not rated yet |
0
|
Drug halts organ damage in inflammatory genetic disorder
A new study shows that Kineret (anakinra), a medication approved for the treatment of rheumatoid arthritis, is effective in stopping the progression of organ damage in people with neonatal-onset multisystem inflammatory disease ...
Medicine & Health / Medications
19 minutes ago |
not rated yet |
0
Molecular profiling reveals differences between primary and recurrent ovarian cancers
There is a need to analyze tumor specimens at the time of ovarian cancer recurrence, according to a new study published in Molecular Cancer Therapeutics. Researchers used a diagnostic technology called molecular profiling to examine ...
8 minutes ago |
not rated yet |
0
|
Both maternal and paternal age linked to autism
Older maternal and paternal age are jointly associated with having a child with autism, according to a recently published study led by researchers at The University of Texas Health Science Center at Houston (UTHealth).
Medicine & Health / Psychology & Psychiatry
1 hour ago |
not rated yet |
0
|
Hovering not hard if you're top-heavy, researchers find
Top-heavy structures are more likely to maintain their balance while hovering in the air than are those that bear a lower center of gravity, researchers at New York University's Courant Institute of Mathematical Sciences ...
Grass to gas: Researchers' genome map speeds biofuel development
Researchers at the University of Georgia have taken a major step in the ongoing effort to find sources of cleaner, renewable energy by mapping the genomes of two originator cells of Miscanthus x giganteus, a large perenn ...
Zuckerberg's focus drives Facebook's ascent
When Mark Zuckerberg showed up to rent Judy Fusco's Los Altos, Calif., house in the fall of 2004, soon after he'd arrived in Silicon Valley, the landlord was immediately struck by his confidence.
Night, weekend delivery OK for babies with birth defects
Weekday delivery is no better than night or weekend delivery for infants with birth defects, according to a new study presented today at The Pregnancy Meeting, the Society for Maternal-Fetal Medicine's annual conference. ...
Sonic Cradle lands spot in TED exhibition
A Simon Fraser University graduate student project that melds music, meditation and modern technology has landed a rare spot as an exhibit at TEDActive 2012 in Palm Springs, California this month.
Cochlear implants may be safe, effective for organ transplant patients
Cochlear implants may be a safe, effective option for some organ transplant patients who've lost their hearing as an unfortunate consequence of their transplant-related drug regime, researchers report.
